Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Syngene International Ltd

NSE: SYNGENE · BSE: 539268 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹361.90
Market cap
₹14,609 Cr
Revenue (annual)
₹3,739 Cr
Net profit (annual)
₹316.7 Cr
P/E (TTM)
66.1×Sector 47.4×
Promoter holding
52.59%-0.09% QoQ
FII holding
11.82%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:18 IST NSE
Other Announcement

Syngene International Other Announcement

Syngene International Limited has issued a communication to shareholders regarding the remittance of the final dividend for the financial year 2025-26.

18:43 IST NSE
Other Announcement

Syngene International Other Announcement

B S R & Co. LLP resigned as statutory auditors of Syngene's material subsidiary, SSSL, effective July 7, 2026. The resignation aims to align auditors across the group.

19:05 IST BSE
Other Announcement

Syngene International Other Announcement

Syngene International announced an updated list of KMPs authorized to determine event materiality. Effective July 01, 2026, Mr. Siddharth Mittal will succeed Mr. Peter Bains as Managing Director and CEO. Mr. Deepak Jain (CFO) and Mr. Chethan Yogesh (CS) remain authorized alongside the new CEO.